Quick Search:         Advanced Search
Chinese Version
Online office
Journal Online
Download
Top
Links
孙克伟,陈斌,黄裕红,伍玉南,周小青.凉血解毒、清热化湿和凉血解毒、健脾温阳法治疗慢性重型肝炎的临床观察[J].,2006,(11):981-983
凉血解毒、清热化湿和凉血解毒、健脾温阳法治疗慢性重型肝炎的临床观察
Clinical Observation on Chronic Severe Hepatitis B Treated by Principles of Cooling-Blood and Detoxicating Combined with Clearing-Heat and Resolving-Damp or Combined with Strengthening-Pi and Warming-Yang
  
DOI:
中文关键词:  慢性重型肝炎  阴阳黄证  辨证治疗  消退黄疸
英文关键词:chronic severe hepatitis B  Yanghuang and Yinhuang syndrome type  treatment depending on syndrome differentiation  eliminating jaundice
基金项目:
Author NameAffiliation
SUN Ke-wei 湖南中医药大学第一附属医院肝病中心 长沙410007 
CHEN Bin 湖南中医药大学第一附属医院肝病中心 长沙410007 
HUANG Yu-hong 湖南中医药大学第一附属医院肝病中心 长沙410007 
伍玉南 湖南中医药大学第一附属医院肝病中心 长沙410007 
周小青 湖南中医药大学第一附属医院肝病中心 长沙410007 
Hits: 1410
Download times: 4
中文摘要:
      目的观察凉血解毒、清热化湿法(简称清热化湿法)和凉血解毒、健脾温阳法(简称健脾温阳法)治疗慢性重型肝炎阴阳黄证的初步疗效,为黄疸的中医治疗提供思路。方法采用随机、对照方法,进行中医辨证治疗慢性重型肝炎43例,重点观察比较清热化湿、健脾温阳两法消退黄疸的作用。结果治疗4周后,清热化湿组22例,有效16例(72·7%),无效6例(27·3%);健脾温阳组21例,有效19例(90·5%),无效2例(9·5%);两组疗效比较差异无显著性。TBIL:治疗后两组均下降(P<0·01),且健脾温阳组下降的幅度大于清热化湿组(P<0·05);凝血酶原活动度:健脾温阳组上升幅度优于清热化湿组(P<0·05);ALT:两组均降低(P<0·05),但两组间比较差异无显著性。结论凉血解毒、健脾温阳法治疗慢性重型肝炎阴阳黄证的疗效优于凉血解毒、清热化湿法。
英文摘要:
      ObjectiveTo observe the therapeutic efficacy on chronic severe hepatitis B (CSH) patients of Yanghuang and Yinhuang syndrome type by principles of cooling-blood and detoxicating combined with clearing-heat and resolving dampness (PA) or with strengthening-Pi and warming-yang (PB), respectively. Methods Forty-three patients with CSH were randomly divided into two groups, group A (22 cases) treated with PA and group B (21 cases) with PB. The therapeutic efficacy, laying stress on the effect in eliminating jaundice, was observed. Results The efficacy in group B was effective in 19 cases (90.5), and ineffective in 2(9.5), while in group A, effective in 16 (72.7) and ineffective in 6 (27.3). Levels of TBIL and ALT were significantly lower in both groups (P<0.05 or P<0.01), and the descending extent was greater, the thrombinogen activity was higher in group B than that in group A after treatment (P<0.05), no significant difference in ALT was found between the two groups. Conclusion The efficacy of PB is better than that of PA on CSH with Yanghuang and Yinghuang syndrome.
View Full Text  View/Add Comment  Download reader